Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Stage IVB recurrent Nasopharyngeal Carcinoma

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Treatment of Stage IVB and Recurrent Nasopharyngeal Cancer

Broader topic: Nasopharyngeal Carcinoma

Source population
Not part of this definition
Disease extent
recurrent
Treatment line
Not part of this definition
Stage
IVB
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
    1. class
      prior therapy
      status
      stated
    derivation status
    source-attested
    derivation note
    Scoped from an NCI treatment-summary heading. NCI PDQ is an evidence summary, not a practice guideline, and only the dimensions the heading states are part of this definition.
    source wording
    Treatment of Stage IVB and Recurrent Nasopharyngeal Cancer

    Study evidence for this setting

    7 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

    NCT00492089 · Registry condition search · Scope: unclear

    Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

    1 outcome links · 2 safety-group records · 0 quality-of-life measures

    →

    NCT01256385 · Registry condition search · Scope: unclear

    Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

    6 outcome links · 2 safety-group records · 0 quality-of-life measures

    →

    NCT01806675 · Registry condition search · Scope: unclear

    18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

    5 outcome links · 3 safety-group records · 1 quality-of-life measures

    →

    NCT02123511 · Registry condition search · Scope: unclear

    Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

    6 outcome links · 2 safety-group records · 3 quality-of-life measures

    →

    NCT02388932 · Registry condition search · Scope: unclear

    Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

    6 outcome links · 1 safety-group records · 1 quality-of-life measures

    →

    NCT02538510 · Registry condition search · Scope: unclear

    Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

    4 outcome links · 2 safety-group records · 0 quality-of-life measures

    →

    NCT03581786 · Source cited / selected · Scope: unclear

    The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

    6 outcome links · 2 safety-group records · 1 quality-of-life measures

    →
    Source relationships and population-mapping limitations
    bindings
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice